ACAM2000
ACAM2000 is a product approval indicated for active immunization against smallpox disease for persons determined to be at high risk for smallpox infection.
Related Articles
Minimize the Impact of COVID-19: Updated Guidance from the CDC
COVID-19 is not over, especially for Latinos. To help people stay vigilant in stopping the spread, the CDC recently published an updated Summary of Guidance for Minimizing the Impact of COVID-19 on Individual Persons, Communities, and Health Care Systems. “To prevent medically significant COVID-19 illness and death, persons must understand their risk, take steps to …
The post Minimize the Impact of COVID-19: Updated Guidance from the CDC appeared first on Salud America.
Partner Spotlight: NCUIH Addresses Infection Control in Native Healthcast!
The US Centers for Disease Control and Prevention’s Project Firstline program provides all healthcare workers – no matter their role or educational background – the infection control training and resources they need to protect themselves, their patients, and their coworkers from infectious diseases. Now in its third year, Project Firstline is made up of a diverse …
The post Partner Spotlight: NCUIH Addresses Infection Control in Native Healthcast! appeared first on Salud America.
